Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry
|
October 26, 2011
Drug-drug interactions associated with antiplatelet therapy
Steven P Dunn, Tracy E Macaulay
Current Cardiology Reports
|
April 19, 2023
Phosphodiesterase Type 5 Inhibitors and Oral Nitrates in Male Patients with Ischemic Heart Disease
Matthew J Morrisette, Steven P Dunn
Cornea
|
April 1, 2015
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial
Gabriel Sosne, Steven P Dunn, Chaesik Kim
Journal of Pharmacy Practice
|
August 16, 2014
Angioedema related to Angiotensin inhibitors
Stephanie E Knecht, Steven P Dunn, Tracy E Macaulay
JACC. Cardiovascular Interventions
|
December 22, 2012
Drug-drug interactions in cardiovascular catheterizations and interventions
Steven P Dunn, David R Holmes, David J Moliterno
The Annals of Pharmacotherapy
|
March 24, 2011
The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema
Craig James Beavers, Steven P Dunn, Tracy E Macaulay
Cardiovascular & Hematological Disorders Drug Targets
|
January 1, 2010
Clopidogrel-proton pump inhibitor interaction: a primer for clinicians
Christopher Allen, Steven P Dunn, Tracy E Macaulay, et al.
Cornea
|
January 25, 2008
Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy
David G Heidemann, Steven P Dunn, Christopher Y C Chow
Pharmacogenomics and Personalized Medicine
|
December 11, 2012
Impact of genetic polymorphisms on clinical response to antithrombotics
Kena J Lanham, Julie H Oestreich, Steven P Dunn, et al.
Annals of the New York Academy of Sciences
|
October 12, 2012
Thymosin β4: a potential novel dry eye therapy
Gabriel Sosne, Ping Qiu, George W Ousler, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Cardiovascular & Hematological Agents in Medicinal Chemistry
|
October 26, 2011
Drug-drug interactions associated with antiplatelet therapy
Steven P Dunn, Tracy E Macaulay
Current Cardiology Reports
|
April 19, 2023
Phosphodiesterase Type 5 Inhibitors and Oral Nitrates in Male Patients with Ischemic Heart Disease
Matthew J Morrisette, Steven P Dunn
Cornea
|
April 1, 2015
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial
Gabriel Sosne, Steven P Dunn, Chaesik Kim
Journal of Pharmacy Practice
|
August 16, 2014
Angioedema related to Angiotensin inhibitors
Stephanie E Knecht, Steven P Dunn, Tracy E Macaulay
JACC. Cardiovascular Interventions
|
December 22, 2012
Drug-drug interactions in cardiovascular catheterizations and interventions
Steven P Dunn, David R Holmes, David J Moliterno
The Annals of Pharmacotherapy
|
March 24, 2011
The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema
Craig James Beavers, Steven P Dunn, Tracy E Macaulay
Cardiovascular & Hematological Disorders Drug Targets
|
January 1, 2010
Clopidogrel-proton pump inhibitor interaction: a primer for clinicians
Christopher Allen, Steven P Dunn, Tracy E Macaulay, et al.
Cornea
|
January 25, 2008
Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy
David G Heidemann, Steven P Dunn, Christopher Y C Chow
Pharmacogenomics and Personalized Medicine
|
December 11, 2012
Impact of genetic polymorphisms on clinical response to antithrombotics
Kena J Lanham, Julie H Oestreich, Steven P Dunn, et al.
Annals of the New York Academy of Sciences
|
October 12, 2012
Thymosin β4: a potential novel dry eye therapy
Gabriel Sosne, Ping Qiu, George W Ousler, et al.
Page
of 5